title: Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod.
authors.affiliation: Regional Pharmacovigilance Center Tessin, Lugano Regional Hospital, Via Tesserete 46, 6900, Lugano, Switzerland.
authors.forename: Raffaela
authors.initials: R
authors.lastname: Bertoli
authors.forename: François
authors.initials: F
authors.lastname: Girardin
authors.forename: Stefan
authors.initials: S
authors.lastname: Russmann
authors.forename: Bernhard H
authors.initials: BH
authors.lastname: Lauterburg
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D009025:Morpholines / Q000009:adverse effects* / Q000627:therapeutic use; D011928:Raynaud Disease / Q000139:chemically induced*; D000077593:Reboxetine; D017366:Serotonin Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018759:Adrenergic Uptake Inhibitors; D007211:Indoles; D009025:Morpholines; D017366:Serotonin Receptor Agonists; C105050:tegaserod; D000077593:Reboxetine